67 related articles for article (PubMed ID: 2496700)
1. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae].
Mancilla-Ramírez J; Nurko-Shein S; Castellanos-Cruz C; Santos-Preciado JI
Bol Med Hosp Infant Mex; 1989 Feb; 46(2):89-93. PubMed ID: 2496700
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
[TBL] [Abstract][Full Text] [Related]
3. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
Hill HR; Bathras JM
Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
[TBL] [Abstract][Full Text] [Related]
4. [Phosphatidylcholine induces an increase in the production of interleukin-6 and improves survival of rats with neonatal sepsis caused by Klebsiella pneumoniae].
Mancilla-Ramírez J; Dinarello CA; Santos-Preciado JI
Gac Med Mex; 1995; 131(1):14-22. PubMed ID: 7493735
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model.
Lachmann RA; van Kaam AH; Haitsma JJ; Verbrugge SJ; Delreu F; Lachmann B
Exp Lung Res; 2004 Jun; 30(4):251-60. PubMed ID: 15204832
[TBL] [Abstract][Full Text] [Related]
6. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
[TBL] [Abstract][Full Text] [Related]
7. Abolition of resistance to Klebsiella pneumoniae by anti-polymorphonuclear leucocyte IgG.
Bullen JJ; Leach PA; Lange L
Immunology; 1980 Jan; 39(1):47-52. PubMed ID: 6991395
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies.
Fischer GW; Hemming VG; Hunter KW; Gloser H; Bachmayer H; Von Pilar CE; Helting T; Weisman LE; Wilson SR; Baron PA
Pediatr Infect Dis; 1986; 5(3 Suppl):S171-5. PubMed ID: 3520501
[TBL] [Abstract][Full Text] [Related]
9. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Magliulo E; Piantieri G; Cafarelli A; Cruciani M
Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
[TBL] [Abstract][Full Text] [Related]
11. Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.
Dickneite G; Pâques EP
Thromb Haemost; 1993 Feb; 69(2):98-102. PubMed ID: 8456437
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with Chloranphenicol of neonatal sepsis-meningitis by gram-negative bacteria (author's transl)].
Rodríguez-Alarcón Gómez J; Jaquotot R; López-Chico D
An Esp Pediatr; 1977 Apr; 10(4):381-8. PubMed ID: 327883
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous immunoglobulin in the treatment of neonatal septicemia].
Mancilla-Ramírez J; González-Yunes R; Castellanos-Cruz C; García-Roca P; Santos-Preciado JI
Bol Med Hosp Infant Mex; 1992 Jan; 49(1):4-11. PubMed ID: 1304766
[TBL] [Abstract][Full Text] [Related]
14. Anticomplementary activity and the safety of intravenous immunoglobulin.
Rousell RH; Budinger MD; Keppler DC; Victor R; Minaga T
Clin Ther; 1989; 11(1):143-50. PubMed ID: 2497981
[TBL] [Abstract][Full Text] [Related]
15. Second place winner of the Conrad Jobst Award in the gold medal paper competition. Increased antibiotic effectiveness in a model of surgical infection through continuous infusion.
Naziri W; Cheadle WG; Trachtenberg LS; Montgomery WD; Polk HC
Am Surg; 1995 Jan; 61(1):11-5. PubMed ID: 7832374
[TBL] [Abstract][Full Text] [Related]
16. Efficaciousness of immunoglobulin G prophylaxis on mortality and physiological variables in gram-negative peritonitis in rodents.
Emerson TE; Lurton JM; Collins MS
Circ Shock; 1985; 17(3):213-22. PubMed ID: 3907885
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
19. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
Knudsen JD
Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
[TBL] [Abstract][Full Text] [Related]
20. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
